COMMUNIQUÉS West-GlobeNewswire

-
Publication of the annual report and invitation to the annual shareholders' meeting
23/03/2018 -
DBV Technologies Announces Closing of Global Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
23/03/2018 -
DBV Technologies annonce la réalisation de son offre globale et l'exercice de la totalité de l'option de surallocation
23/03/2018 -
IntelGenx to Report Fourth Quarter and Full-Year 2017 Financial Results on March 29, 2018 – Conference Call to Follow
23/03/2018 -
Corizon Health Names New CMO
23/03/2018 -
K2M Group Holdings, Inc. to Participate in the 17th Annual Needham Healthcare Conference
23/03/2018 -
Heart Institute Inaugurates State-of-The-Art Building Expansion
23/03/2018 -
L’Institut de cardiologie inaugure ses nouvelles installations de pointe
23/03/2018 -
eFFECTOR Announces Appointment of John W. Smither to its Board of Directors
23/03/2018 -
RuddCo Inc. Announces Cannabis Operations Expansion into Jamaica
23/03/2018 -
TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn's disease in Europe
23/03/2018 -
TiGenix et Takeda annoncent l'autorisation d'Alofisel® (darvadstrocel) pour le traitement des fistules périanales complexes dans la maladie de Crohn en Europe
23/03/2018 -
Spine Injury Solutions Schedules Fiscal Year 2017 Conference Call for March 29, 2018 at 4:20 p.m. ET
23/03/2018 -
MJ Biotech Inc. Florida’s MarijuanaDoctor.com Q & A on MoneyTV.NET
23/03/2018 -
Progressive Care Announces 2017 Annual Report Conference Call and Webcast with Investors on March 27, 2018
23/03/2018 -
CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies
23/03/2018 -
Alzheimer’s Virtual Reality Sensory Experience Featured at Upcoming ASA Workshop
23/03/2018 -
Portola Pharmaceuticals Receives and Plans to Appeal Negative CHMP Opinion Regarding Marketing Authorization for Betrixaban in the European Union
23/03/2018 -
CURE Pharmaceutical Announces Closing of $1 Million Bridge Financing and Prepares to Uplist to NASDAQ
23/03/2018
Pages